Anemia in a population-based ibd cohort (ICURE): Still high prevalence after 1 year, especially among pediatric patients

Inflammatory Bowel Diseases

Volumn 20, Issue 12, 2014, Pages 2266-2270

  Sjöberg, Daniel ^a   Holmström, Tommy ^b   Larsson, Märit ^c   Nielsen, Anne Lie ^b   Holmquist, Lars ^d   Rönnblom, Anders ^d  

^a FALUN HOSPITAL   (Sweden)

^b Aland Central Hospital   (Finland)

^c Malar Hospital   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anemia; Crohn's disease; Epidemiology; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; HEMOGLOBIN; IRON; MESALAZINE; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHILD; COHORT ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; STEROID THERAPY; ULCERATIVE COLITIS; WORLD HEALTH ORGANIZATION; ADOLESCENT; CLINICAL TRIAL; COLITIS, ULCERATIVE; COMPLICATION; INFANT; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SWEDEN; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84925715313     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000191     Document Type: Article

References (18)

1. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190-1197.
2. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6:142-150.
3. Kulnigg S, Gasche C. Systematic review: managing anemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24:1507-1523.
4. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):44S-49S.
5. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1299-1307.
6. Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010;4:642-648.
7. Rejler M, Tholstrup J, Andersson-Gare B, et al. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol. 2012;47:937-942.
8. Hoivik ML, Reinisch W, Cvancarova M, et al. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther. 2014;39:69-76.
9. Ott C. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a populationbased cohort. Gastroenterol Res Pract. 2012;10:595970.
10. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44:838-845.
11. Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009-results from the IBD cohort of the Uppsala Region (ICURE). J Crohns Colitis. 2013;7:e351-e357.
12. Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and clinical course of Crohn's disease during the first year-results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis. 2014;8:215-222.
13. WHO. Nutritional anaemias. Report of a WHO scientific group. WHO Technical Report Series. Geneva, Switzerland: World Health Organization; 1968.
14. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
15. Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46:304-309.
16. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545-1553.
17. Gerasimidis K, Barclay A, Papangelou A, et al. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis. 2013;19:2411-2422.
18. Wiskin AE, Fleming BJ, Wootton SA, et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis. 2012;6: 687-691.